X0306 4 2022-09-14 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001237676 VANCE DOLLY RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 true EVP Corp. Affairs, G.C., Sect. Employee Stock Option (right to buy) 2 2022-09-14 4 A 0 81250 0 A 2029-01-23 Common Stock 81250 81250 D The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met. The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met. /s/Dolly Vance 2022-09-16